Overview
Huangkai Zhou practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Glioblastoma, Astrocytoma, Triple-Negative Breast Cancer, and Glioma.
They are actively involved in clinical research, co-authoring 26 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Huangkai Zhou
Is Huangkai Zhou a top-rated expert for Glioblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Huangkai Zhou is classified as an Experienced expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Huangkai Zhou participate in research or clinical trials?
Yes. Huangkai Zhou has published 26 articles and abstracts on conditions like Glioblastoma. You can view a list of Huangkai Zhou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaZhou isExperienced. Learn about Astrocytoma.
- Brain TumorZhou isExperienced. Learn about Brain Tumor.
- GlioblastomaZhou isExperienced. Learn about Glioblastoma.
- GliomaZhou isExperienced. Learn about Glioma.
- Gliomatosis CerebriZhou isExperienced. Learn about Gliomatosis Cerebri.
- Triple-Negative Breast Cancer